Source - SMW
Dr. George Morris, Chief Operations Officer of Valirx (VAL) (LSE:VAL) will be giving a briefing at the SHARES Investor Evening on 5th October 2016. It will take place in Edinburgh at an investor evening being organised by Shares Magazine; the event is supported by Alliance Trust Savings. 

Valirx Plc is an oncology-focussed Biopharmaceutical Company, developing treatments and diagnostics. Technologies are selected by using rigorous clinical and commercial processes to address unmet market needs. Clinical lead product is VAL201, a peptide for prostate cancer with follow-on indications in ovarian and breast cancers and endometriosis. Product VAL401, is a small molecule reformulation for lung cancers.

The Company’s proprietary technology platform, GeneICE, enables selective silencing of rebellious genes’ inappropriate activity. VAL101, the first GeneICE therapeutic, targets and reduces expression of Bcl-2, implicated in about half of cancers. GeneICE extension to neurology and inflammatory diseases will follow.

A novel diagnostic, the Nav3 system, detects pre-cancerous, cancerous and metastatic cells in tissue samples even before a tumour forms; indicating potential malignant formation.

The Shares event offers a unique opportunity to hear about the latest plans and strategy from the Directors of UK listed companies and Fund Managers, attendees can personally put forward questions to the presenters.

The event will take place at the Radisson Blu Hotel Edinburgh, 80 High Street, The Royal Mile, Edinburgh EH1 1TH. Registration begins at 17:30 and presentations at 17:55, followed by a drinks and canapes reception where attendees can mingle with the speakers and fellow investors.

Companies presenting include: 
Mark Learmonth, CFO & Director - Caledonia Mining Corporation (CMCL)

Richard Gray, CEO - Scotgold Resources (SGZ)

Neil Ritson, Non-Executive Chairman - Solo Oil (SOLO)

James Parsons, CEO - Sound Energy (SOU)

Dr. George Morris, Chief Operations Officer - Valirx (VAL)
Investors can register now for free at: 

At 9:40am: (LON:VAL) ValiRx PLC share price was 0p at 7.5p